Harbor Capital Advisors, Inc. Viking Therapeutics, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $1.31 Billion
- Q2 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 63,432 shares of VKTX stock, worth $3.43 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
63,432
Previous 8,364
658.39%
Holding current value
$3.43 Million
Previous $686,000
390.23%
% of portfolio
0.26%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
442Shares Held
63.3MCall Options Held
6.23MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$547 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$326 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$277 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$122 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$101 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.15B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...